4.2 Article

A screening strategy for heterologous protein expression in Escherichia coli with the highest return of investment

Journal

PROTEIN EXPRESSION AND PURIFICATION
Volume 81, Issue 1, Pages 33-41

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.pep.2011.08.030

Keywords

High throughput protein production; Recombinant protein expression; Escherichia coli heterologous protein production

Funding

  1. Canadian Institutes for Health Research
  2. Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute
  3. GlaxoSmithKline
  4. Karolinska Institutet
  5. Knut and Alice Wallenberg Foundation
  6. Ontario Innovation Trust
  7. Ontario Ministry for Research and Innovation
  8. Merck Co. Inc.
  9. Novartis Research Foundation
  10. Swedish Agency for Innovation Systems
  11. Swedish Foundation for Strategic Research
  12. Wellcome Trust

Ask authors/readers for more resources

Heterologous protein expression in Escherichia coli is commonly used to obtain recombinant proteins for a variety of downstream applications. However, many proteins are not, or are only poorly, expressed in soluble form. High level expression often leads to the formation of inclusion bodies and an inactive product that needs to be refolded. By screening the solubility pattern for a set of 71 target proteins in different host-strains and varying parameters such as location of purification tag, promoter and induction temperature we propose a protocol with a success rate of 77% of clones returning a soluble protein. This protocol is particularly suitable for high-throughput screening with the goal to obtain soluble protein product for e.g. structure determination. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available